Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$vcel Look at the holdings in this, Microsoft, google, facebook, chevron, Costco, GE, Amazon, Ford , AND VERICEL CORPORATION $VCEL
https://fintel.io/i/first-washington
omg, 74 HOLDINGS AND WE ARE ONE OF THEM WITH THE BIG BOY HOLDINGS
vcel
In two to three years, we are going to be a $30 to $50 stock or more, depends on the blessing of the $$$$ money funds like we got today
https://fintel.io/i/first-washington
YYYEEEAAAAAAAHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH !!!!
$VCEL lasers, do you realize what this means, LOOK LOOK LOOK
https://fintel.io/i/first-washington
Investor First Washington CORP
Portfolio Value $ 1,999,115,000
Current Positions 74
And we are one of them, wowwwwwwwwwwwwwwwwwwwwwwwwwwwwwww
$VCEL Thank you rani9990 from another board https://fintel.io/so/us/vcel
They just proved to wallstreet today VCEL is a player, just wait to next quarter, should be a profitable one, can't wait
https://seekingalpha.com/article/4096867-vericels-vcel-ceo-nick-colangelo-q2-2017-results-earnings-call-transcript?part=single
Currently 18 of our top 28 plans have updated medical policy for MACI. We estimate that this represents approximately half of covered lives and MACI is in final review with several other plans. Notably, a few large payers that have not yet updated ACI policy namely United and Anthem [ph] which we believe account for approximately 30% of covered lives in the US.
I found a company with old info in their website, I think I am going to start surfing the MACI ortho docs and their websites to see who is updating, it will take huge time, maybe BrianIQ can help me, here is an example, but like brianIQ said, there are 657 of them or more, who knows
From the MACI website
Just going to ask if they heard of or do MACI procedures and DD the F out of it
http://www.performanceorthopedics.com/surgical-procedures/knee/carticel-re-implanation/
VCEL
BrianIQ posted a nice link on FDA RMAT regarding VCEL
https://www.biopharma-excellence.com/news/2017/6/18/rmat-fda-started-new-expedited-program-for-cell-therapies
VCEL
IMHO, they have no choice, we have been sub penny forever and its costing them 100,000 in legal and compliance fees to stay on the otc.
The didn't take my advice and roll a medical majuania company into the FLCR shell
Reverse split in the cards here, ??? I see they finally put out an 8-K
8-K events have to be filed timely
https://www.sec.gov/fast-answers/answersform8khtm.html
VCEL
Nice, but looking for over 10 on 03-14-2018 CC for 4th quarter ending 12-31-2017
No wonder why the FDA gave fast track and RMAT
Macrophages, specifically M2 macrophages, have anti-inflammatory and remodeling actions. The macrophages found in ixmyelocel-T show an expression mainly of M2 markers. However, rather than secreting the active heterodimer IL-12 p70 (which have pro-inflammatory functions), ixmyelocel-T macrophages release a comparable amount less than a typical M1 or M2 macrophage. In fact, ixmyelocel-T had shown to secrete elevated levels of IL-10 (anti-inflammatory functions) at a significant level. 7 Finally, with phagocytic properties, these cells could act to remove necrotic tissue and apoptotic cells in diseased or damaged tissues, such as those in dilated cardiomyopathy.8 Actions of these cells have warranted justification in studying ixmyelocel-T for tissue regeneration and repair. In a rat model, an incision was given to the hind-limb along the femoral artery of rats. After intramuscular injections in the ischemic limb, ixmyelocel-T had shown to secrete pro-angiogenic cytokines to allow repair. Nitric oxide, a regulator of blood flow and a proliferation enhancer, was also shown to have increased levels in the rats treated with ixmyelocel-T. Along with NO promotion, ixmyelocel-T has the ability to reduce inflammation and apoptosis in endothelial cells.9
My eyes on are on MACI quarter 3 and 4 for growth, and definitely on Ixmyelocel-T, that is the mac daddy, and with Fast Track, and RMAT status, and the upcoming FDA guidance in 2H2017
wow!
Funny, was just looking at that clinical trial while browsing through the vcel website.
Been watching the careers on the VCEL site, from time to time http://vcel.com/careers/
And that X-cell FDA commercial approval will put us in double digit land, wouldn't you think?
howdy. Haven't posted in a while, just patiently waiting for Q3 and Q4 ending 12-31-2017 to see the growth of MACI and Epicel.
Suggest you look at the 9 month chart, and you will see $3.50 coming short term, in the chart in the link below
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129962445
DRYS
keep dreaming, you will be covering
DRYS going over 2.00 - $2.00 land - cant wait to see clays chart
1.70 vol 7900 Can DRYS put out some boomer news this morning?
Tomorrow clay will do a video chart, any predictions, I say pps hits 1.71 plus or minus w/o news
or, maybe it opens there + -
imho, DRYS way oversold still, and momentum is gaining huge
DRYS
Seems to be the pattern now, hope Significant News is release to propel DRYS into bluesky land, they wouldn't have gotten the 400 plus million if something wasn't in the hopper
Looking at the 9 month chart posted earlier, 3.50 seems a no brainer in the short term
Is DRYS supposed to announce a SHELL contract anytime soon?
Short squeeze tomorrow
Can someone ask VCEL if Epicel can be used to treat this, is there an EPICEL "cure" market in this, since they can grow the body skin over 2 times from a postage size sample from let's say, under the armpit, CAN EPICEL BE USED AFTER REMOVING ACID BURNED SKIN AND REPLACE IT WITH EPICEL SKIN ? You know, remove the acid burned skin and rewrap the body with fresh skin? Has this been tried, would make a great press release, wouldn't you think? What if EPICEL can restore a woman's or a man's or a kid looks, after an acid attack?
http://www.dailymail.co.uk/news/article-4346516/Furious-lover-pours-acid-girlfriend.html
VCEL
drys and tops breaking out
a 5x from here is possible imho, very possible, no brainer 5 to 6 bucks a share soon on News, look at the 5.61 line in the chart
http://www.4-traders.com/DRYSHIPS-INC-33364072/charts/&applet_mode=statique
Great DD realfast95
It is definitely not any competition to VCEL
VCEL Upcoming Events - Tomorrow morning 8am Roth
http://investors.vcel.com/events.cfm
Mar 13, 2017
8:00 AM PT
29th Annual ROTH Conference
? Listen to webcast http://wsw.com/webcast/roth31/register.aspx?conf=roth31&page=vcel&url=http://wsw.com/webcast/roth31/vcel/index.aspx
Mar 14, 2017
11:00 AM PT
2017 Canaccord Genuity Musculoskeletal Conference
? Listen to webcast
http://wsw.com/webcast/canaccord25/register.aspx?conf=canaccord25&page=vcel&url=http://wsw.com/webcast/canaccord25/vcel/index.aspx
http://www.canaccordgenuity.com/en/cm/News-Events/Events/
VCEL
I see there are only 2 sales jobs left http://vcel.com/careers/
And a Clinical Director, Global Medical Affairs Cambridge 03/06/2017
Do we have any pending 60 day decisions coming from the FDA on Ixmyelocel-T that we are expecting any time soon?
Spot on, was listening to the Larry Kudlow show today 03-11-2017
I know the link says 2012 but really it takes you into 03-11-2017
http://www.wabcradio.com/2012/12/09/kudlowpodcasts/
And guest Steve Forbes and Larry Kudlow praised Dr Scott Gottieb for the new Head of the FDA
VCEL
laser, in what quarter coming forward do you think mgmt. will give guidance?
Future is the key, and imho, it is bright. One year from now I think all the longs will be rewarded for their investing patience.
CEO said in the 12-14-2016 CC that VCEL will be profitable in 2017.
Wonder if we will get any Upgrades from these 3 conferences going into Tuesday
Regenerative advanced therapies are eligible for priority review and accelerated approval. It’s our hope that by investigating alternative regulatory paths for ixmyelocel-T will increase the likelihood of accessing the non-dilutive means to commercialize the program. So in summary, we have built a strong foundation for our next phase of growth.
Great question, let me find the earnings call transcript
http://seekingalpha.com/article/4054146-vericels-vcel-ceo-nick-colangelo-q4-2016-results-earnings-call-transcript?page=2
I got to read the transcript, I would believe there are confidentialty agreements signed for non disclosure, if they are in any negotiations. Remember, in the ibox there is that page where they put out last year they were seeking Japanese partnerships.
Also, and more importantly, CEO stated Ixmyelocel-T will go to market NON-Dilutive
I can't believe that no one is pickup up on that.
I 100% agree with you, I was thinking of dividend per share in 3 to 5 years and the projected pps